Fentanyl Patch
Product Images NDC 0378-9122

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Fentanyl (NDC 0378-9122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Medication Guide Fentanyl Packaging Layers (Image 01)

An instructional diagram illustrating the components of a Fentanyl transdermal patch. The image shows the layers including the protective film being peeled back, the backing layer, the drug-containing layer, and the release liner. Arrows label each part of the patch to explain its structure.*

FDA Label Image

Medication Guide Figures A (D)

Illustration showing proper placement of Fentanyl transdermal patches on the body. Figures depict patch application areas on the chest, back, upper arm, and instructions for applying a patch to the arm.*

FDA Label Image

Medication Guide Figures E (Image 03)

An instructional black-and-white illustration labeled 'Figure E' showing a hand holding scissors and cutting the hair on a man's chest, presumably as preparation for applying a transdermal patch. The image depicts the chest and neck area with visible chest hair being trimmed.*

FDA Label Image

Medication Guide Figures F (Image 04)

An instructional illustration labeled as Figure F showing hands opening a sealed pouch containing a pouch or packet. This likely demonstrates the proper method to open the packaging, possibly related to the transdermal fentanyl patch preparation or use.*

FDA Label Image

Medication Guide Figures G (Image 05)

An illustration showing a Fentanyl transdermal patch partially peeled from its protective backing, displayed inside a square foil pouch. The image visually represents the packaging and handling of a Fentanyl patch prior to application.*

FDA Label Image

Medication Guide Figures H (Image 06)

An instructional illustration labeled as Figure H showing hands peeling off a liner from a square transdermal patch, demonstrating how to prepare the patch for application.*

FDA Label Image

Medication Guide Figures I (Image 07)

An instructional illustration depicting proper application of a transdermal patch on the upper chest area, showing a hand placing the patch on the skin, intended for use with transdermal fentanyl patches manufactured by Mylan Pharmaceuticals Inc.*

FDA Label Image

Medication Guide Figures J (Image 08)

An instructional line drawing showing two hands holding a folded Fentanyl transdermal patch. The illustration demonstrates the process of opening or unfolding the patch packaging prior to application.*

FDA Label Image

Medication Guide Figures K (Image 09)

An illustration labeled 'Figure K' showing an open toilet against a plain background with a hand dropping a small rectangular object into the bowl, demonstrating disposal of a medication patch or similar item.*

FDA Label Image

Fentanyl Structural Formula (Image 10)

Chemical structure diagram of fentanyl, illustrating its molecular framework with rings and side chains as typically represented in pharmaceutical chemistry.*

FDA Label Image

Fentanyl Transdermal Protective Film (Image 11)

A line graph showing fentanyl concentration (ng/mL) over time (hours) comparing single (1x) versus multiple (4x) 100 mcg/h fentanyl transdermal systems. The chart depicts the plasma concentration levels rising and falling over approximately 340 hours with error bars indicating variability at each time point.*

FDA Label Image

Figure 1 Serum Fentanyl Concentrations Following Single And Multiple Applications Of Fentanyl Transdermal System 100 Mcg/hr (Image 12)

An instructional diagram of a transdermal patch labeled as Fentanyl. It details the patch's components, including the protective film, backing layer, drug-containing layer, and release liner, illustrating the structural layers of the patch.*

FDA Label Image

Fentanyl Transdermal System 12 Mcg/hr Carton Label (Image 13)

Packaging label for Fentanyl Transdermal System 12 mcg/hr patch by Mylan Pharmaceuticals Inc. The label includes directions, warnings, and ingredient information. The box is primarily white with blue accents and shows the NDC 0378-9119-98. It specifies in vivo delivery of 12 mcg/hr for 72 hours and cautions about serious respiratory risks. Designed for opioid-tolerant patients only, with instructions to keep out of children's reach.*

FDA Label Image

Fentanyl Transdermal System 25 Mcg/hr Carton Label (Image 14)

Packaging label for Fentanyl Transdermal System 25 mcg/hr by Mylan Pharmaceuticals Inc. The label features warnings about serious respiratory risks, instructions to not use if the seal is broken, and includes medication guide references. It specifies the delivery of 25 mcg/hr fentanyl for 72 hours, contains 2.55 mg fentanyl per patch, and states it is for opioid-tolerant patients only. The label includes inactive ingredients dimethicone NF and silicone adhesive, storage instructions at 20° to 25°C, and a contact phone number for questions.*

FDA Label Image

Fentanyl Transdermal System 37.5 Mcg/hr Carton Label (Image 15)

Packaging label for Fentanyl Transdermal System 37.5 mcg/hr by Mylan Pharmaceuticals Inc. The label includes dosage, safety warnings regarding respiratory risks, and storage instructions. The package contains five transdermal systems, each delivering 37.5 mcg/hr fentanyl over 72 hours, and is intended for opioid-tolerant patients only.*

FDA Label Image

Fentanyl Transdermal System 50 Mcg/hr Carton Label (Image 16)

Packaging label for Fentanyl Transdermal System 50 mcg/hr patch by Mylan Pharmaceuticals Inc. The label includes warnings, ingredient info, usage instructions, and a patient guide reference. It indicates a 72-hour delivery of 50 mcg/hr fentanyl per patch and contains five systems per package. The label specifies storage conditions, narcotic use recording, and safety warnings about serious breathing problems.*

FDA Label Image

Fentanyl Transdermal System 62.5 Mcg/hr Carton Label (Image 17)

Fentanyl Transdermal System 62.5 mcg/hr patch packaging label from Mylan Pharmaceuticals Inc. The label shows dosage strength, instructions on safe use, warnings about serious breathing problems, narcotic use recording, inactive ingredients, and contact information for the manufacturer. The design includes a blue and white color scheme with yellow accents and highlights that the product is for opioid-tolerant patients only.*

FDA Label Image

Fentanyl Transdermal System 75 Mcg/hr Carton Label (Image 18)

Fentanyl Transdermal System 75 mcg/hr patch carton from Mylan Pharmaceuticals Inc. The packaging highlights the strength 75 mcg/hr and indicates it is for opioid-tolerant patients only. It includes warnings against use for certain pain types, storage instructions, and a note on the active fentanyl content per system. The design features purple text on a white background with blue side panels and Mylan branding.*

FDA Label Image

Fentanyl Transdermal System 87.5 Mcg/hr Carton Label (Image 19)

Packaging label for Fentanyl Transdermal System 87.5 mcg/hr by Mylan Pharmaceuticals Inc. The label states it is for opioid-tolerant patients only and includes safety warnings, inactive ingredients (dimethicone NF and silicone adhesive), storage instructions, and contact information. The label highlights the dosage form as a transdermal system with a delivery rate of 87.5 mcg/hr.*

FDA Label Image

Fentanyl Transdermal System 100 Mcg/hr Carton Label (Image 20)

Fentanyl Transdermal System 100 mcg/hr patch packaging label from Mylan Pharmaceuticals Inc. The label highlights the dosage strength of 100 mcg/hr, intended for opioid-tolerant patients only. It includes safety and usage instructions, warning against use by those with breathing problems, and instructs to read the enclosed Medication Guide. The packaging also provides storage instructions and a section for narcotic use recording.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.